Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)
About this episode
This episode discusses a 2024 post hoc analysis of early onset type 2 diabetes and the drug Tirzepatide as published in Diabetes Care.
In this episode of Hormone Insight, we examine a 2024 post hoc analysis published in Diabetes Care.
More episodes of Hormone Insight
- HORMONE INSIGHT -- THE WEEK IN DIABETES & ENDOCRINOLOGY -- Episode 004 | April 24, 2026
- The Week in Diabetes and Endocrinology April 17, 2026
- Episode 002: LDL Under 55 Wins Big, Medicare Covers GLP-1, and Second Weekly Insulin Emerges -- The Week in Diabetes & Endocrinology (April 10, 2026)
- The Week in Diabetes and Endocrinology -- April 3, 2026
- Exploring Semaglutide: Therapy for Obesity and Heart Failure
- Semaglutide vs Canagliflozin for Type 2 Diabetes
Explore listener stats, chart rankings, contacts and more on the Hormone Insight podcast page.